Table 1.
Clinical parameters of 277 study subjects.
Parametera | Non-obstructive azoospermia (NOA) | Severe oligozoospermia (SO) | Moderate oligozoospermia (MO) | Normozoospermic fertile men (NORM)b |
---|---|---|---|---|
Subgroup size (n) | 73 | 84 | 58 | 62 |
Age (years) | 33.7 (21.6–58.0) | 35.6 (18.1–55.4) | 32.4 (20.0–57.8) | 31.0 (22.0–53.0) |
Height (cm) | 180 (169–197) | 178 (166–198) | 181.5 (162–210) | 180 (171–193) |
Weight (kg) | 85.9 (54.3–127.7) | 85.2 (55.7–125.8) | 86.2 (59.7–123.0) | 80.3 (62.0–107.4) |
BMI (kg/m2) | 26.1 (18.7–35.7) | 26.9 (18.4–37.8) | 25.7 (18.0–34.4) | 25.0 (19.7–34.2) |
Total testis volume (ml) | 27 (7–49) | 28 (7–55) | 28 (18–56) | 47.5 (34–100) |
Semen volume (ml) | 3.4 (0.5–8.9) | 3.6 (0.6–8.2) | 4.0 (1.4–9) | 4.1 (1.8–9.4) |
Total sperm count (× 106/ ejaculate) | 0 (0–0) | 2.4 (0.004–9.9) | 21.3 (10–37.8) | 430.3 (49.5–1540) |
Sperm concentration (× 106/ml) | 0 (0–0) | 0.9 (0.001–14) | 5.0 (1.8–19) | 115 (15–355) |
Progressive A + B motility (%)c | n/a | 14.5 (0–70) | 30 (0–60) | 55 (41–84) |
Sperm with normal morphology (%)d | n/a | 0 (0–12) | 2 (0–12) | 14 (2–27)e |
FSH (IU/l) | 24.9 (4.8–70.5) | 17.4 (2.7–41.1) | 13.4 (4.1–30.5) | 3.2 (0.8–6.8) |
LH (IU/l) | 8.3 (2.7–27.8) | 5.9 (2.2–16.4) | 4.8 (2.5–14.6) | 3.4 (1.5–6.8) |
Total testosterone (nmol/l) | 14.0 (1.0–45.0) | 16.5 (3.5–46.0) | 16.5 (5.8–41.1) | 16.7 (9.1–30.1) |